Table 3

Secondary outcomes: ST-resolution

Total
(N=361)
Placebo (N=181)Metoprolol (N=180)P value
% STR for the sum of ST elevation57.6 (58.0)59.3 (48.7)55.8 (66.2)0.56
0.45
No STR (<30%)73/361 (20.2)33/181 (18.2)40/180 (22.2)
Partial STR (30%–70%)101/361 (28.0)57/181 (31.5)44/180 (24.4)
Complete STR (>70%)187/361 (51.8)91/181 (50.3)96/180 (53.3)
% STR for the sum of ST elevation or depression62.9 (44.5)62.7 (40.7)63.1 (48.1)0.94
0.57
No STR (<30%)64/361 (17.7)33/181 (18.2)31/180 (17.2)
Partial STR (30%–70%)102/361 (28.3)55/181 (30.4)47/180 (26.1)
Complete STR (>70%)195/361 (54.0)93/181 (51.4)102/180 (56.7)
% STR for the maximum ST elevation56.0 (49.0)56.2 (47.0)55.9 (51.1)0.96
0.68
No STR (<30%)79/361 (21.9)36/181 (19.9)43/180 (23.9)
Partial STR (30%–70%)122/361 (33.8)68/181 (37.6)54/180 (30)
Complete STR (>70%)160/361 (44.3)77/181 (42.5)83/180 (46.1)
% STR for the maximum absolute ST elevation or depression57.8 (43.1)57.5 (43.4)58.1 (43.0)0.90
0.68
No STR (<30%)72/361 (19.9)34/181 (18.8)38/180 (21.1)
Partial STR (30%–70%)130/361 (36.0)69/181 (38.1)61/180 (33.9)
Complete STR (>70%)159/361 (44.0)78/181 (43.1)81/180 (45.0)
  • Data are n/N (%) or mean (SD).

  • AF, atrial fibrillation; SR, sinus rhythm; STR, ST-segment resolution.